BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37748043)

  • 21. α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.
    Hone AJ; McIntosh JM; Azam L; Lindstrom J; Lucero L; Whiteaker P; Passas J; Blázquez J; Albillos A
    Mol Pharmacol; 2015 Nov; 88(5):881-93. PubMed ID: 26330550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors.
    Tae HS; Gao B; Jin AH; Alewood PF; Adams DJ
    Biochem Pharmacol; 2021 Aug; 190():114638. PubMed ID: 34062129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
    Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
    J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Biological Activity of Novel α-Conotoxins Derived from Endemic Polynesian Cone Snails.
    Souf YM; Lokaj G; Kuruva V; Saed Y; Raviglione D; Brik A; Nicke A; Inguimbert N; Dutertre S
    Mar Drugs; 2023 Jun; 21(6):. PubMed ID: 37367681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors.
    Kompella SN; Cuny H; Hung A; Adams DJ
    Mol Pharmacol; 2015 Dec; 88(6):993-1001. PubMed ID: 26438212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
    Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
    Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
    Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
    Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
    Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of fluorescent analogs of alpha-conotoxin MII.
    Vishwanath VA; McIntosh JM
    Bioconjug Chem; 2006; 17(6):1612-7. PubMed ID: 17105243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor.
    Ren J; Li R; Ning J; Zhu X; Zhangsun D; Wu Y; Luo S
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29925760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.
    Azam L; McIntosh JM
    Acta Pharmacol Sin; 2009 Jun; 30(6):771-83. PubMed ID: 19448650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.
    Grishin AA; Wang CI; Muttenthaler M; Alewood PF; Lewis RJ; Adams DJ
    J Biol Chem; 2010 Jul; 285(29):22254-63. PubMed ID: 20466726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholine promotes binding of α-conotoxin MII at α3 β2 nicotinic acetylcholine receptors.
    Sambasivarao SV; Roberts J; Bharadwaj VS; Slingsby JG; Rohleder C; Mallory C; Groome JR; McDougal OM; Maupin CM
    Chembiochem; 2014 Feb; 15(3):413-24. PubMed ID: 24420650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. αD-Conotoxins in Species of the Eastern Pacific: The Case of
    Hernández-Sámano AC; Falcón A; Zamudio F; Batista CVF; Michel-Morfín JE; Landa-Jaime V; López-Vera E; Jeziorski MC; Aguilar MB
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31336928
    [No Abstract]   [Full Text] [Related]  

  • 35. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
    Franco A; Kompella SN; Akondi KB; Melaun C; Daly NL; Luetje CW; Alewood PF; Craik DJ; Adams DJ; Marí F
    Biochem Pharmacol; 2012 Feb; 83(3):419-26. PubMed ID: 22108175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic Residues at Position 11 of α-Conotoxin LvIA Influence Subtype Selectivity between α3β2 and α3β4 Nicotinic Receptors via an Electrostatic Mechanism.
    Haufe Y; Kuruva V; Samanani Z; Lokaj G; Kamnesky G; Shadamarshan P; Shahoei R; Katz D; Sampson JM; Pusch M; Brik A; Nicke A; Leffler AE
    ACS Chem Neurosci; 2023 Dec; 14(24):4311-4322. PubMed ID: 38051211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel 4/6-type alpha-conotoxin ViIA selectively inhibits nAchR α3β2 subtype.
    Li L; Liu N; Ding R; Wang S; Liu Z; Li H; Zheng X; Dai Q
    Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):1023-8. PubMed ID: 26511093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo and in vitro testing of native α-conotoxins from the injected venom of Conus purpurascens.
    Hoggard MF; Rodriguez AM; Cano H; Clark E; Tae HS; Adams DJ; Godenschwege TA; Marí F
    Neuropharmacology; 2017 Dec; 127():253-259. PubMed ID: 28917942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Function Elucidation of a New α-Conotoxin, MilIA, from
    Peigneur S; Devi P; Seldeslachts A; Ravichandran S; Quinton L; Tytgat J
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.